BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 25271250)

  • 21. [Metabolic Outcomes of Primary Aldosteronism Patients Receiving Adrenalectomy or Spironolactone Treatments].
    Xu C; Chen T; Mo D; Zhang T; Zhou F; Tian H; Ren Y
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2023 Nov; 54(6):1227-1232. PubMed ID: 38162054
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cardiac dimensions are largely determined by dietary salt in patients with primary aldosteronism: results of a case-control study.
    Pimenta E; Gordon RD; Ahmed AH; Cowley D; Leano R; Marwick TH; Stowasser M
    J Clin Endocrinol Metab; 2011 Sep; 96(9):2813-20. PubMed ID: 21632817
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adrenalectomy improves arterial stiffness in primary aldosteronism.
    Strauch B; Petrák O; Zelinka T; Wichterle D; Holaj R; Kasalický M; Safarík L; Rosa J; Widimský J
    Am J Hypertens; 2008 Oct; 21(10):1086-92. PubMed ID: 18654122
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adrenalectomy reverses myocardial fibrosis in patients with primary aldosteronism.
    Lin YH; Wu XM; Lee HH; Lee JK; Liu YC; Chang HW; Lin CY; Wu VC; Chueh SC; Lin LC; Lo MT; Ho YL; Wu KD;
    J Hypertens; 2012 Aug; 30(8):1606-13. PubMed ID: 22688266
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiovascular outcomes in patients with primary aldosteronism after treatment.
    Catena C; Colussi G; Nadalini E; Chiuch A; Baroselli S; Lapenna R; Sechi LA
    Arch Intern Med; 2008 Jan; 168(1):80-5. PubMed ID: 18195199
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of changes in cardiac structure after treatment in secondary hypertension.
    Yoshitomi Y; Nishikimi T; Abe H; Yoshiwara F; Suzuki T; Ashizawa A; Nagata S; Kuramochi M; Matsuoka H; Omae T
    Hypertension; 1996 Mar; 27(3 Pt 1):319-23. PubMed ID: 8698432
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Unilateral primary aldosteronism with spontaneous remission after long-term spironolactone therapy.
    Yoneda T; Demura M; Takata H; Kometani M; Karashima S; Yamagishi M; Takeda Y
    J Clin Endocrinol Metab; 2012 Apr; 97(4):1109-13. PubMed ID: 22337911
    [TBL] [Abstract][Full Text] [Related]  

  • 28. KCNJ5 gene somatic mutations affect cardiac remodelling but do not preclude cure of high blood pressure and regression of left ventricular hypertrophy in primary aldosteronism.
    Rossi GP; Cesari M; Letizia C; Seccia TM; Cicala MV; Zinnamosca L; Kuppusamy M; Mareso S; Sciomer S; Iacobone M; Mantero F; Pessina AC
    J Hypertens; 2014 Jul; 32(7):1514-21; discussion 1522. PubMed ID: 24759126
    [TBL] [Abstract][Full Text] [Related]  

  • 29. EFFICACY OF SPIRONOLACTONE IN ANTIHYPERTENSIVE THERAPY IN PATIENTS WITH RESISTANT HYPERTENSION IN COMBINATION WITH RHEUMATOID ARTHRITIS.
    Kondratiuk V; Stakhova A; Hai O; Karmazina O; Karmazin Y
    Georgian Med News; 2020 Dec; (309):51-59. PubMed ID: 33526730
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characteristics predicting clinical improvement and cure following laparoscopic adrenalectomy for primary aldosteronism in a large cohort.
    Worth PJ; Kunio NR; Siegfried I; Sheppard BC; Gilbert EW
    Am J Surg; 2015 Oct; 210(4):702-9. PubMed ID: 26323999
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of aldosterone in left ventricular hypertrophy in hypertension.
    Matsumura K; Fujii K; Oniki H; Oka M; Iida M
    Am J Hypertens; 2006 Jan; 19(1):13-8. PubMed ID: 16461184
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Relation Between the Degree of Left Ventricular Mass Regression and Serum Potassium Level Change in Patients With Primary Aldosteronism After Adrenalectomy.
    Liao CW; Chen A; Lin YT; Chang YY; Wang SM; Wu VC; Hung CS; Wu KD; Chueh SC; Lin YH;
    J Investig Med; 2015 Aug; 63(6):816-20. PubMed ID: 26083251
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic factors of primary aldosteronism.
    Ou YC; Yang CR; Chang CL; Chang CH; Wu HC; Ho HC; Lin HS; Chang YY
    Zhonghua Yi Xue Za Zhi (Taipei); 1996 Feb; 57(2):118-23. PubMed ID: 8634926
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effectiveness of eplerenone or spironolactone treatment in preserving renal function in primary aldosteronism.
    Fourkiotis V; Vonend O; Diederich S; Fischer E; Lang K; Endres S; Beuschlein F; Willenberg HS; Rump LC; Allolio B; Reincke M; Quinkler M;
    Eur J Endocrinol; 2013 Jan; 168(1):75-81. PubMed ID: 23033260
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regression of left ventricular hypertrophy in primary aldosteronism after adrenalectomy: a meta-analysis of echocardiographic studies.
    Cuspidi C; Tadic M; Sala C; Quarti-Trevano F; Gherbesi E; Mancia G; Grassi G
    J Hypertens; 2021 Apr; 39(4):775-783. PubMed ID: 33044383
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of antihypertensive therapy on blood pressure and left ventricular hypertrophy in patients with severe hypertension.
    Sumino H; Nakamura T; Kanda T; Sakamaki T; Sato K; Saito Y; Hoshino J; Kurashina T; Ono Z; Takahashi T; Ichikawa S; Kurabayashi M; Nagai R
    Jpn Heart J; 2000 May; 41(3):339-48. PubMed ID: 10987352
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hemodynamic and Non-Hemodynamic Components of Cardiac Remodeling in Primary Aldosteronism.
    Pan CT; Wu XM; Tsai CH; Chang YY; Chen ZW; Chang CC; Lee BC; Liao CW; Chen YL; Lin LC; Chang YR; Hung CS; Lin YH
    Front Endocrinol (Lausanne); 2021; 12():646097. PubMed ID: 33953695
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Will the lessons from primary aldosteronism change the treatment of hypertension and left ventricular hypertrophy?
    Auchus RJ; Drazner MH
    Hypertension; 2007 Nov; 50(5):837-9. PubMed ID: 17909118
    [No Abstract]   [Full Text] [Related]  

  • 39. Outcomes of adrenalectomy in patients with primary hyperaldosteronism--a single centre experience.
    Hartmann I; Grepl M; Vidlar A; Smakal O; Vaclavik J; Frysak Z; Dolezel M; Student V
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2014 Dec; 158(4):583-90. PubMed ID: 25471827
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In-treatment reduced left atrial diameter during antihypertensive treatment is associated with reduced new-onset atrial fibrillation in hypertensive patients with left ventricular hypertrophy: The LIFE Study.
    Wachtell K; Gerdts E; Aurigemma GP; Boman K; Dahlöf B; Nieminen MS; Olsen MH; Okin PM; Palmieri V; Rokkedal JE; Devereux RB
    Blood Press; 2010 Jun; 19(3):169-75. PubMed ID: 20438307
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.